JPC CAPITAL PARTNERS (OTCBB: JPCI)
"Up 69.44% on Wednesday"

Detailed Quote: http://www.otcpicks.com/quotes/JPCI.php

JPC Capital Partners, Inc., a broker/dealer, provides an opportunity for public companies to raise capital through the sale of equity positions in the private market primarily in the United States. The company also provides financial consulting services. It provides private placement transactions through Internet. JPC Capital Partners was founded in 1999. It was formerly known as Corpfin.com, Inc. and changed its name to JPC Capital Partners, Inc. in 2004. The company is based in Alpharetta, Georgia.

JPCI News:

March 26 - JPC Capital Partners, Inc. Executes Stock Purchase Agreement and Share Exchange With Componus, Inc.

JPC Capital Partners, Inc. (OTCBB: JPCI), a licensed broker-dealer based in Atlanta, Georgia, announced that it has executed a stock purchase agreement and share exchange with Componus, Inc., a Nevada corporation ("Componus"), involved in providing the automotive, trucking, transportation, railway, and petroleum industries with raw, finished, and assembled components.

The Agreement provides for the acquisition of Componus by JPC Capital Partners, Inc. whereby Componus will become a wholly owned subsidiary of JPCI. In connection with the acquisition of Componus, and after taking into effect a 1-for-2 reverse split of JPCI common shares, JPCI will issue 89,000,000 total shares of common stock. This will represent approximately 87.25% of the total issued and outstanding common stock of JPCI after the transaction is closed. These shares will be issued in exchange for all of the issued and outstanding shares of Componus. Upon completion of the Closing, Componus intends to elect a new board of directors and appoint new officers.

JPC Capital Partners CEO, John Canouse, stated: "After reviewing all of our strategic options, a merger with Componus was deemed to be the most effective strategy available to enhance shareholder value. Componus is an established company with assets and a tremendous revenue potential in the multi-billion dollar metal forging and automotive supply industry. We see this as a great opportunity for JPC Capital shareholders."

ABOUT COMPONUS, INC.

Componus, Inc. ("Componus") is a Nevada Corporation involved in the multi-billion dollar industry of providing automotive, trucking, railway and petroleum industries with raw, finished and assembled components.

TOBACCO ONE INCORPORATED (OTC: TBCO)
"Up 65.00% on Wednesday"

Detailed Quote: http://www.otcpicks.com/quotes/TBCO.php

Tobacco One Inc. plans to acquire companies focused on the manufacturing and direct national distribution of current high-volume, high-margin tobacco products.

TBCO News:

March 25 - Tobacco One Inc. (Formerly VTWN) Commences Trading under the Symbol TBCO

Tobacco One Inc. (OTC: TBCO) plans to acquire companies focused on the manufacturing and direct national distribution of current high volume high margin tobacco products. The national distribution network will serve to properly brand our new cutting-edge product line currently under development. Tobacco One’s industry focus is in the area of specialty cigarettes, cigars, and other tobacco products (OTP), as well as revolutionary new smoking alternative products. The Company looks to finalize its first acquisition in the 1st Qtr of 2008 and has additional acquisitions under review.

The Company is also focusing on international sales opportunities with an emphasis in Latin America. Currently, the Company is negotiating with several, multi-billion dollar Latin American companies. These negotiations have already produced “Letters of Intent,” as well as representative agreements, further facilitating the inevitable distribution agreements that the Company expects in place during Qtr. 1 of 2008.

Upon completion of necessary acquisitions, the company plans to develop a two stage approach to improve the current organic growth rate of 30% to an estimated 300%. The first step is to develop a sales team in the local/regional marketplace where the company operates. Along with this local/regional approach, the sales team will receive training to cross-market the other services and products that the company provides. The second phase of the sales program is to develop a national sales group. This group will establish distribution channels through both direct sales, as well as agreements with national and regional distributors. Additionally, the national sales group will market the company’s products to the largest Fortune 500 convenient store chains. The relationships with these large clients have been established by the management team over the past 25 years, primarily as suppliers to these large companies.

Upon completion of the necessary and required audits, the company will apply for a Bulletin Board, Amex, or NASDAQ small cap listing.

ECOLOCLEAN INDUSTRIES (OTC: ECCI)
"Up 66.67% on Wednesday"

Detailed Quote: http://www.otcpicks.com/quotes/ECCI.php

Ecoloclean Industries, Inc. is the owner of two wholly owned subsidiaries, Ecoloclean Industries, Inc. and World Environmental Technologies, Inc. and utilize various remediation techniques and technologies. Ecoloclean Industries, Inc., using the E-C WaterPure System(tm), provides environmental waste remediation to treat and remove impurities in contaminated wastewater and/or polluted liquids and solids for a variety of industries, including, refineries, papers mills, petroleum and petrochemical industries. For more information about the Company, please visit www.ecoloclean.com.

ECCI News:

March 26 - Ecoloclean Industries Expands Operations to Texas Oil and Gas Fields

E-C WaterPure System Scores Excellent Test Results and Interest, as Company Establishes Operations to Service the Barnett Shale

Ecoloclean Industries, Inc. (OTC: ECCI) has expanded and returned to its origins in the oil and gas fields of the United States. Royis Ward, Chairman and CEO of Ecoloclean Industries, Inc., is certain this focused expansion will create optimal return for the E-C WaterPure System(tm) technology, customers, company and investors. To accelerate acceptance and contract acquisitions, the ECCI strategy includes the enlistment and support of leading exploration companies and regulatory agencies. The management team of ECCI has over 80 years of combined experience in oil and gas exploration being applied in the very fields they will now be servicing. According to Royis Ward, “Our technology has been proven effective in several industries and applications. We originated our technology and began this company out of these oil and gas fields. With our proven technology and our oil and gas experience, ECCI has been able to earn some opportunities here that are most often reserved for larger and more established companies. We are very pleased to be realizing this support with the introduction of our E-C WaterPure System(tm) here at the Barnett Shale.”

The choice of the Barnett Shale as the focal point of the expansion and launch of Ecoloclean Industries and the E-C WaterPure System(tm) is due in part to the size of the field, and the use of the hydraulic fracturing process. Discovered in 1981, the Barnett Shale (field) encompasses five thousand square miles, across 18 counties near Dallas / Ft. Worth. This is one of the largest natural gas deposits in the United States. It boasts plentiful reserves estimated at greater than 27 trillion cubic feet. To extract the gas at volumes that are economical and efficient, production companies must use the hydraulic fracturing process. The process utilizes millions of gallons of water for each well. The process greatly increases the permeability and the release of trapped gas deposits. The water pumped into the wells and approximately 80 percent of the water returns to the surface. Historically, the recovered water is discarded in disposal wells due to its saline content. The cost of this current form wastewater disposal is in excess of $1.2 billion dollars per year to the industry.

The gas industry, in partnership with communities and regulatory agencies, has become more aggressive about testing and employing measures to conserve and recycle water. Additionally, the ongoing drought over the past few years has made water conservation essential to the health of the communities and industry. “Industry and agencies are working hand-in-hand to find the most effective methods to protect and preserve our natural resources. Clearly, our technology helps reach optimal recycling levels for our most precious resource, water. We are very proud of our team that worked tirelessly to deliver the best possible products and services to our communities and customers. This is an exciting and important opportunity that will make a difference for our community, the environment, our customers, and our company,” added Royis Ward.

In the Barnett Field, there are currently 7000 gas wells operating and additional 4,350-permitted locations. The market for the E-C WaterPure System's(tm) E-C technology fits very well with the fracturing of both new wells, and older wells may that be re-fractured multiple times and operate for many years.

ENTREMED INCORPORATED (NASD: ENMD)
"Up 1.92% on Wednesday"

Detailed Quote: http://www.otcpicks.com/quotes/ENMD.php

EntreMed, Inc., a clinical-stage pharmaceutical company, develops and commercializes oncology and anti-inflammatory drugs. Its products under clinical development include Panzem NCD in Phase II clinical trials as a monotherapy for the treatment of ovarian cancer, hormone refractory prostate cancer, multiple myeloma, and glioblastoma; Phase II clinical trials in combination with Avastin for the treatment of carcinoid cancer; Phase Ib Part A and B clinical trials as single agent for the treatment of advanced cancers; and Phase Ib trials in combination with paclitaxel for the treatment of metastatic breast cancer. The company is also developing MKC-1, a small molecule cell cycle inhibitor, which is in Phase II clinical trials as a single agent for the treatment of metastatic breast cancer; Phase II clinical trials in combination with Alimta for the treatment of advanced cancer and non-small cell lung cancer; and Phase I clinical trial as a single agent for the treatment of hematological malignancies. In addition, it is conducting clinical studies for ENMD-1198, a chemical compound for treatment of patients with advanced cancer. Further, EntreMed's preclinical compounds and programs include 2ME2 for the treatment of rheumatoid arthritis; ENMD-981693, a kinase inhibitor for oncology; tubulin inhibitors; and histone deacetylase inhibitors. It has co-operative research and development agreement with the National Cancer Institute for 2-Methoxyestradiol (2ME2) and 2ME2 analogs as inhibitors of Hypoxia Inducible Factor-1 alpha; and a collaborative research agreement with the University Of New South Wales and Children's Childrens Cancer Institute Australia For Medical Research to map pathways involved in the mechanism of action for its lead compound, 2-methoxyestradiol, and analogs of 2ME2. The company was founded in 1991 and is based in Rockville, Maryland.

ENMD News:

March 25 - EntreMed to Present at BioCentury Future Leaders in the Biotech Industry Conference

EntreMed, Inc. (NASD: ENMD) a clinical-stage pharmaceutical company developing therapeutics for the treatment of cancer and inflammatory diseases, announced that James S. Burns, President and Chief Executive Officer, will present a Corporate overview at the BioCentury Future Leaders in the Biotech Industry Conference, to be held at the Millennium Broadway Hotel & Conference Center, March 27, 2008. Mr. Burns' presentation is scheduled for Thursday, March 27, 2008 at 4:00 p.m. (local time).

Mr. Burns' live presentation will be web cast and can be accessed through the Company's web site at www.entremed.com. An archive will be available on the web site for approximately 90 days.

PATIENT SAFETY TECHNOLOGIES (OTCBB: PSTX)
"Up 35.45% on Wednesday"

Detailed Quote: http://www.otcpicks.com/quotes/PSTX.php

Patient Safety Technologies, Inc., together with its subsidiaries, engages in the research and development of products and services focused primarily in the health care and medical products field. The company develops and manufactures patient safety products and services. It provides Safety-Sponge System, which reduces the number of retained sponges and towels in patients during surgical procedures, and allows for counting of surgical sponges. This system consists of a handheld scanner/imager/computer and bar coded surgical dressings. The company, formerly Franklin Capital Corporation, was founded in 1959 and is headquartered in Temecula, California.

PSTX News:

March 26 - A Large Not-For-Profit Catholic Health Care System Adopts SurgiCount Computerized Sponge Counting System

Bar Coded Sponge / Scanner System Chosen to Help Reduce RFO Thus Improving Patient Safety Across the Health Care Network

SurgiCount Medical, a division of Patient Safety Technologies (OTCBB: PSTX), the manufacturer of the Safety-Sponge™ surgical sponge counting system, announced a two-year contract to provide its computerized sponge counting system to a network of fourteen hospitals primarily located in California and Texas.

“After an extensive evaluation of the Safety-Sponge™ System, the network determined that the SurgiCount System was the most effective method to prevent retained foreign objects," said Rick Bertran, President of SurgiCount Medical. “In making their decision, the network evaluated systems on their ability to provide consistent and standardized patient care, measurable outcomes, documentation and overall cost. We are thrilled to have such a large network as a customer and look forward to working with all fourteen of their hospitals.”

SurgiCount continues to demonstrate the effectiveness of its Safety-Sponge™ System to numerous medical facilities throughout the nation. Currently, we are in contract negotiations with several of these large medical facilities, and we believe that a significant number will begin converting to the Safety-Sponge™ System. Although there are several variables in determining what revenue an individual hospital may generate, it has been our experience that a hospital performing 10,000 – 15,000 procedures a year would generate between $120,000 and $220,000 in recurring revenues. To the extent hospitals convert to our system as anticipated, overall revenues from sales of the Safety-Sponge™ System will begin to accelerate.

CODA OCTOPUS GROUP (OTCBB: CDOC)
"Up 31.11% on Wednesday"

Detailed Quote: http://www.otcpicks.com/quotes/CDOC.php

Coda Octopus Group, Inc. develops underwater technologies for imaging, mapping, defense, and survey applications. Its primary products include Octopus precision motion sensors; Coda and Octopus marine software and systems; Octopus thermal printers; and the Coda Echoscope a real time 3D subsea sonar with various applications within navies and for subsea construction. The company also offers Octopus and Coda range of data acquisition and interpretation products. In addition, it provides engineering services, including design, manufacturing, and consultancy services primarily to the defense sector, as well as to the nuclear power and pharmaceutical industries. Coda Octopus Group has operations in the United States, the United Kingdom, and Norway. The company was founded in 1994 and is based in New York, New York.

CDOC News:

March 26 - Coda Octopus Says Jacksonville to Become First US Port to Deploy New Technology to Prevent an Underwater Terrorist Attack

Coda Octopus Group, Inc. (OTCBB: CDOC) announced the first deployment in the United States by a local law enforcement agency since the 9/11 attacks of a new generation of port security technology to respond to underwater threats.

The Company said it had received an order from the City of Jacksonville, Florida, to deliver its Underwater Inspection System, developed for the United States Coast Guard, to the Jacksonville Sheriff’s Office, whose team of highly trained public safety / Bomb Squad divers will be using the system on their small patrol vessels. The UIS utilizes Coda’s patented real time 3D sonar technology, the Coda Echoscope™ to identify and classify objects underwater, enabling much more rapid and effective searches of ports and waterways.

Coda Octopus expects to deliver the UIS, which has already been deployed by the US Coast Guard and in the Middle East and Asia, to the Jacksonville Sheriff’s Office within the next thirty days. The Company also said that a large number of US ports have shown a significant interest in the UIS, and that it expects to be able to confirm at least one additional order over the next 60 days.

“The UIS will greatly enhance our capability to safeguard our ports and underwater critical infrastructure” said Chief Roy Henderson, who heads the Jacksonville Sheriff's Office Homeland Security Division.

Jason Reid, Coda Octopus President and CEO, said he viewed the Jacksonville order as a “significant milestone” for Coda Octopus. He commented that “It was shortly after 9/11 that I had my first view of a 3D real time sonar device in its earliest prototype form, and the Company’s commitment to commercialize this technology was indeed inspired by the attacks. It has been a long journey, but we always envisaged the ports of the United States as a very large and important market for these devices. Today, we are more certain than ever of the size of this potential market, the uniqueness and appropriateness of the technology and of the products we have to offer, and of the interest on the part of US Coast Guard and of large numbers of port authorities throughout the United States.”